Bristol-Myers Squibb Company (BMY)
NYSE·Healthcare·Drug Manufacturers - General
$58.23
+0.79%
Mkt Cap $120.73B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 5, 2026 | $12.28B | $12.50B | +1.80% | $1.23 | $1.26 | +2.44% | — | — |
| Q4 2025 Oct 30, 2025 | $11.85B | $12.22B | +3.14% | $1.52 | $1.63 | +7.24% | — | — |
| Q3 2025 Jul 31, 2025 | $11.44B | $12.27B | +7.21% | $1.09 | $1.46 | +33.94% | — | — |
| Q2 2025 Apr 24, 2025 | $10.70B | $11.20B | +4.73% | $1.49 | $1.80 | +20.81% | — | — |
| Q1 2025 Feb 6, 2025 | $11.57B | $12.34B | +6.70% | $1.47 | $1.67 | +13.61% | — | — |
| Q4 2024 Oct 31, 2024 | $11.26B | $11.89B | +5.57% | $1.49 | $1.80 | +20.81% | — | — |
| Q3 2024 Jul 26, 2024 | $11.54B | $12.20B | +5.73% | $1.62 | $2.07 | +27.78% | — | — |
| Q2 2024 Apr 25, 2024 | $11.48B | $11.87B | +3.34% | -$4.41 | -$4.40 | +0.23% | — | — |
| Q1 2024 Feb 2, 2024 | $11.19B | $11.48B | +2.55% | $1.52 | $1.70 | +11.84% | — | — |
| Q4 2023 Oct 26, 2023 | $10.97B | $10.97B | -0.04% | $1.76 | $2.00 | +13.64% | — | — |
| Q3 2023 Jul 27, 2023 | $11.80B | $11.23B | -4.87% | $1.99 | $1.75 | -12.06% | — | — |
| Q2 2023 Apr 27, 2023 | $11.49B | $11.34B | -1.36% | $1.98 | $2.05 | +3.54% | — | — |
| Q1 2023 Feb 2, 2023 | $11.19B | $11.41B | +1.97% | $1.71 | $1.82 | +6.43% | — | — |
| Q4 2022 Oct 25, 2022 | $11.14B | $11.22B | +0.73% | $1.83 | $1.99 | +8.74% | — | — |
| Q3 2022 Jul 27, 2022 | $11.42B | $11.89B | +4.09% | $1.79 | $1.93 | +7.82% | — | — |
| Q2 2022 Apr 29, 2022 | $11.36B | $11.65B | +2.53% | $1.92 | $1.96 | +2.08% | — | — |
| Q1 2022 Feb 4, 2022 | $12.04B | $11.98B | -0.48% | $1.83 | $1.83 | +0.00% | — | — |
| Q4 2021 Oct 27, 2021 | $11.63B | $11.62B | -0.04% | $1.91 | $2.00 | +4.71% | — | — |
| Q3 2021 Jul 28, 2021 | $11.61B | $11.70B | +0.81% | $1.88 | $1.93 | +2.66% | — | — |
| Q2 2021 Apr 29, 2021 | $11.56B | $11.07B | -4.21% | $1.80 | $1.74 | -3.33% | — | — |